AngioDynamics, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-05-312026-02-282025-11-302025-08-312025-05-312025-02-282024-11-302024-08-31
Total Revenue86.6M78.4M79.4M75.7M80.2M72.0M72.8M67.5M
Cost of Goods Sold37.2M36.9M37.3M33.9M37.9M33.1M32.9M30.8M
Gross Profit49.4M41.5M42.1M41.9M42.2M38.9M39.9M36.7M
R&D Expenses8.2M7.1M7.8M6.4M6.6M6.9M6.4M6.3M
Operating Expenses69.8M47.9M44.6M52.5M48.0M48.8M51.0M49.8M
Operating Income-20.4M-6.4M-2.5M-10.7M-5.8M-10.0M-11.1M-13.1M
Other Income / Gains9.3M-1.6M-3.9M-182K-322K5.6M246K433K
Net Income-11.4M-8.1M-6.3M-10.9M-6.0M-4.4M-10.7M-12.8M
EPS (Diluted)-0.28-0.19-0.15-0.26-0.15-0.11-0.26-0.31
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.5710.5290.5310.5530.5270.540.5480.544
General And Administrative Expenses10.3M10.7M10.2M12.6M10.2M10.5M10.4M11.0M
Selling And Marketing Expenses31.1M27.4M26.7M28.1M26.4M25.5M25.6M25.6M
Selling General And Administrative Expenses41.4M38.2M36.9M40.7M36.7M36.0M36.0M36.6M
Other Expenses20.2M2.7M05.4M4.7M5.9M8.6M7.0M
Cost And Expenses107.0M84.9M81.9M86.4M85.9M82.0M83.9M80.6M
Interest Income00003K135K234K606K
Interest Expense105K88K102K4K0000
Depreciation And Amortization-17.4M5.6M5.8M6.0M5.8M6.3M6.9M6.8M
Ebitda-28.4M-2.4M-436K-4.8M2.2M-329K1.8M-1.9M
Ebitdaratio-0.327-0.031-0.005-0.0640.027-0.0050.025-0.029
Operating Income Ratio-0.235-0.082-0.031-0.141-0.072-0.139-0.152-0.194
Income Before Tax-11.0M-8.1M-6.4M-10.8M-6.1M-4.4M-10.8M-12.7M
Income Before Tax Ratio-0.127-0.103-0.08-0.143-0.076-0.061-0.149-0.188
Income Tax Expense370K12K-5K65K-60K-2K-110K133K
Net Income Ratio-0.132-0.103-0.08-0.144-0.075-0.061-0.147-0.19
Epsdiluted-0.28-0.19-0.15-0.26-0.15-0.11-0.26-0.31
Weighted Average Shs Out41.5M41.6M41.4M41.2M41.0M40.9M40.9M40.7M
Weighted Average Shs Out Dil41.5M41.6M41.4M41.2M41.0M40.9M40.9M40.7M